Login here to update your profile  
My Profile

Emmanuel W. Smith, PhD
Research Assistant, Molecular Medicine


Postdoctoral Scholar Research

profile Image
Email: esmith3@health.usf.edu
Phone: (813) 396-9188
Office: MDC, 3524
Mailing address 12901 Bruce B. Downs Blvd ,MDC07
Tampa, FL 33612
  • PhD, Medical Sciences, University Of South Florida, Tampa, United States - 2014.
  • PhD, Medical Sciences, University of South Florida, USA - 2014.
  • MS, Molecular Medicine, University of South Florida, USA - 2012.
  • BS, Biology, University of South Florida, USA - 2009.
    Research Summary

    Our lab focuses on structure-based drug discovery through the use of X-ray crystallography and molecular docking. My main focus has been on chemokine proteins CXCL12 and CCL21 and their implication in cancer metastasis, but also on P.aeruginosa proteins LpxA and LpxD. X-ray crystallography is a tool used to determine the atomic and molecular structure of protein crystals. This provides invaluable information about the protein, such as structural characterization of active sites. Once an active site is characterized, a rational drug design approach can be used. Molecular docking is a computational tool that can be used to predict the binding orientation of small molecules to proteins. This can be used to study possible conformations a molecule might take in a protein active site, but can also be used to computationally screen millions of compounds in search of potential drug candidates.


    Selected Publications
  • Jehle K, Cato L, Neeb A, Muhle-Goll C, Jung N, Smith EW, Buzon V, Carbó LR, Estébanez-Perpiñá E, Schmitz K, Fruk L, Luy B, Chen Y, Cox MB, Bräse S, Brown M, Cato AC. Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif. The Journal of biological chemistry. 289(13) : 8839-51, 2014.
  • Smith E, Liu Y, Getschman AE, Peterson F, Ziarek JJ, Li R, Volkman BF, Chen Y. Structural analysis of a novel small molecule ligand bound to the CXCL12 chemokine. Journal of medicinal chemistry. : , 2014.
  • Hung MS, Xu Z, Chen Y, Smith E, Mao JH, Hsieh D, Lin YC, Yang CT, Jablons DM, You L. Hematein, a casein kinase II inhibitor, inhibits lung cancer tumor growth in a murine xenograft model. International journal of oncology. 43(5) : 1517-22, 2013.
  • Nichols DA, Jaishankar P, Larson W, Smith E, Liu G, Beyrouthy R, Bonnet R, Renslo AR, Chen Y. Structure-based design of potent and ligand-efficient inhibitors of CTX-M class A β-lactamase. Journal of medicinal chemistry. 55(5) : 2163-72, 2012.
  • Ziarek JJ, Liu Y, Smith E, Zhang G, Peterson FC, Chen J, Yu Y, Chen Y, Volkman BF, Li R. Fragment-based optimization of small molecule CXCL12 inhibitors for antagonizing the CXCL12/CXCR4 interaction. Current topics in medicinal chemistry. 12(24) : 2727-40, 2012.

  • Positions Held

    Profile last modified on 12/28/2014